tirzepatide weight loss nejm New in the January 30, 2025, issue of NEJM: for Heart Failure and Obesity (SUMMIT trial) https://nej.md/4hRGaTY Continuation of Oral Anticoagulation during TAVI (POPular PAUSE TAVI trial) https://nej.md/3XllHys Lentiviral Gene Therapy 📢 New in NEJM: Tirzepatide

Smaller, more frequent meals tend to feel better and support steadier nutrient intake throughout the day

Our electrophysiological analyses revealed that exendin 939 likely binds to the extracellular side of TRPV1, offering selective and potent antagonism for pain relief

Massage: Apply to your face and body, massaging gently in circular motions

Terms with an adjusted P 1 of the RRM2 gene in the PTC tissues was used as the cut-off point for the expression level to classify the samples into the high-expression group and the low-expression group, and further analyses showed that, as shown in Supplementary Table 2 , we found that the RRM2 expression level was correlated with tumor size (P = 0.0048), which may indicate that RRM2 acts as a potential oncogenic factor in PTC

Our commitment is to make healthcare accessible, personalized, and compassionate